Copper, zinc and selenium imbalance in Moroccan haemodialysis patients and its correlation to lipid peroxidation

Rachid Eljaoudi, Mourad Errasfa, Mohammed Benyahia, Abdelali Bahadi, Yahia Cherrah, Azeddine Ibrahimi, Driss Elkabbaj


Background: Haemodialysis patients are at risk of developing trace elements imbalance and lipid peroxidation. The present study was aimed to assess plasma levels of copper (Cu), zinc (Zn), selenium (Se) and malondialdehyde (MDA) of haemodialysis patients and to investigate the possible effect of haemodialysis on these trace elements and MDA imbalance.

Methods: Blood samples of fifty hemodialysis patients and forty healthy controls subjects were analyzed for determination of hemoglobin, albumin, creatinine, urea and high-sensitivity C-reactive protein (hs-CRP). Cu, Zn and Se were determined in plasma (before and after hemodialysis) and erythrocytes and MDA in plasma before and after hemodialysis.

Results: The study showed that, plasma Zn and Se concentrations were lower in haemodialysis patients compared to that of healthy controls, while plasma Cu, MDA and Cu/Zn ratio were higher.  Plasma Cu/Zn ratios were positively correlated to MDA and weakly correlated to hs-CRP levels whereas plasma Se concentrations were inversely correlated to MDA. In addition, MDA levels increased after haemodialysis session.

Conclusions: Based on the results of the present study regarding the imbalance of trace elements in haemodialysis patients, it seems reasonable to periodically assess the trace elements status and consider possible correctional therapy in case of deficiency.



Trace element, Oxidative stress, Haemodialysis, Lipid peroxidation

Full Text:



Perihan O, Ergul KB, Neslihan D, Filiz A. The activity of adenosine deaminase and oxidative stress biomarkers in scraping samples of acne lesions. J Cosmet Dermatol. 2012;11(4):323–8.

Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox Biol. 2013;1(8):483-91.

Lin TH, Chen JG, Liaw JM, Juang JG. Trace elements and lipid peroxidation in uremic patients on hemodialysis. Biol Trace Elem Res. 1996; 51(3):277-83.

Miura Y, Nakai K, Suwabe A, Sera K. Trace elements in renal disease and haemodialysis. Nucl Instr Meth Phys Res. 2002;189(1-4):443-9.

Zima T, Tesar V, Mestek O, Nemecek K. Trace elements in end stage renal disease. 2. Clinical implication of trace elements. Blood Purif. 1999;17(4):187-98.

Zima T, Mestek O, Nemecek K, Bartova V, Fialova J, Tesar V, et al: Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif. 1998;16(5):253-60.

Shrimpton R, Gross R, Darnton-Hill I, Young M. Zinc deficiency: what are the most appropriate interventions? BMJ. 2005;330(7478):347-9.

Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982;2(8291):175-9.

Viktorínová A, Tošerová E, Križko M, and Ďuračková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated haemoglobin in patients with diabetes mellitus. Metabolism. 2009;58(10):1477-82.

Bertinato J, Zouzoulas A. Considerations in the development of biomarkers of copper status. J AOAC Int. 2009;92(5):1541-50.

Bonaventura P, Benedetti G, Albarède F, Miossec P. Zinc and its role in immunity and inflammation. Autoimmune Rev. 2015;14(4):277-85.

Cruz KJ, de Oliveira AR, Marreiro Ddo N. Antioxidant role of zinc in diabetes mellitus. World J Diabetes. 2015;6(2):333-7.

Duntas LH, Benvenga S. Selenium: an element for life. Endocrine. 2015;48(3):756-75.

Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R et al. Trace elements in haemodialysis patients: a systematic review and meta-analysis. BMC Med. 2009;7:25.

Druml W. Nutritional management of acute renal failure. Am J Kidney Dis. 2001;37(1 Suppl 2):S89–94.

Richard MJ, Ducros V, Foret M, Arnaud J, Coudray C, Fusselier M, et al. Reversal of selenium and zinc deficiencies in chronic haemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation-Time-course of glutathione peroxidase repletion and lipid peroxidation decrease. Biol TR Elem Res. 1993;39(2-3):149–59.

Fukunaga K, Yoshida M, Nakazono N. A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. Biomed Chromatogr. 1998;12(5):300-3.

Batista MN, Cuppari L, de Fatima Campos Pedrosa L, Almeida Md, de Almeida JB, de Medeiros AC, et al. Effect of end-stage renal disease and diabetes on zinc and copper status. Biol Trace Elem Res. 2006;112(1):1-12.

Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF. Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res. 2006;109(2):115-21.

Navarro-Alarcon M, Reyes-Pérez A, Lopez-Garcia H, Palomares-Bayo M, Olalla-Herrera M, Lopez-Martinez MC. Longitudinal study of serum zinc and copper levels in haemodialysis patients and their relation to biochemical markers. Biol Trace Elem Res. 2006;113(3):209-22.

Zagrodzki P, Barton H, Walas S, Folta M, Stompor T, Janusz-Grzybowska E, et al. Selenium status indices, laboratory data, and selected biochemical parameters in end stage renal disease patients. Biol Trace Elem Res. 2007;116(1):29-41.

Bozalioğlu S, Ozkan Y, Turan M, Simşek B. Prevalence of zinc deficiency and immune response in short-term haemodialysis. J Trace Elem Med Biol. 2005;18(3):243-9.

Sandhu JS, Narang APS, Bhatia KL, Adlakha J, Khullar D. Trace elements and oxidative stress in chronic renal failure. Trace Elem Electroly 2005;22(3):233-5.

Bogye G, Tompos G, Alfthan G. Selenium depletion in haemodialysis patients treated with polysulfone membranes. Nephron. 2000;84(2):119-23.

Ogunro PS, Olujombo FA, Ajala MO, Oshodi TT. The effect of a membrane dialyzer during haemodialysis on the antioxidant status and lipid peroxidation of patients with end-stage renal disease. Saudi J Kidney Dis Transpl. 2014;25(6):1186-93.

Weissgarten J, Berman S, Bilchinsky R, Modai D and Averbukh Z. Total Cell-Associated Zn and Cu and Proliferative responsiveness of Peripheral Blood Mononuclear Cells From Patients on Chronic Haemodialysis. Metabolism. 2001;50(3):270-6.

Prodanchuk M, Makarov O, Pisarev E, Sheiman B, Kulyzkiy M. Disturbances of trace element metabolism in ESRD patients receiving hemodialysis and hemodiafiltration. Cent European J Urol. 2014;66(4):472-6.

Ghoreshi Z, Ahaley SK, Rasooli I. Effect of haemodialysis on trace elements in patients with acute and chronic renal failure. MJIRI. 2001;14(4):329-31.

Roxboroug H E, Millar C A, McEneny J and Young I S. Carbamylation inhibit the ferroxidase activity of caeruloplasmin, Biochem. Biophysical Res. Commun. 1995;214(3):1073–8.

Pang JF. Relation between treatment with traditional Chinese medicine for recurrent aphthous ulcer and human zinc and copper. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1992;12(5):280–2.

Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, et al. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients. J Nephrol. 2004;17(5):715-20.

Gaetke LM, Chow-Johnson HS, Chow CK. Copper: toxicological relevance and mechanisms. Arch Toxicol. 2014;88(11):1929-38.

Anees M, Mumtaz A, Frooqi S, Ibrahim M, Hameed F. Serum trace elements (aluminium, copper, zinc) in hemodialysis patients. Biomedica. 2011;27(11):106 – 10.

Foote JW, Hinks LJ. Zinc absorption in haemodialysis patients. Ann Clin Biochem. 1988;25 (Pt 4):398-402.

Torre MLR, Alarcon MN, Moral LM, Serrana HL, Bayo MP, Lopez MJO, et al. Serum Zn levels and Cu/Zn Ratios worsen in hemodialysis patients, implying increased cardiovascular risk: A 2- year Longitudinal study. Biological Trace Element Research. 2014;158(2):129-35.

Guo CH, Chen PC, Yeh MS, Hsiung DY, Wang CL. Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem. 2011;44(4):275-80.

Bonomini M, Forster S, Manfrini V, De Risio F, Steiner M, Vidovich MI, et al. Geographic factors and plasma selenium in uremia and dialysis. Nephron. 1996;72(2):197-204.

Zachara BA, Gromadzińska J, Wasowicz W, Zbróg Z. Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review. Acta Biochim Pol. 2006;53(4):663-77.

Kamińska-Galwas B, Grzeszczak W, Jedryczko A, Pachelski J. Level of zinc, copper, selenium and nickel in serum of patients treated for chronic renal failure with haemodialysis-influence of erythropoietin therapy. Pol Arch Med Wewn. 1993;89(5):368-76.

Geradi G, usberti M, Martini G, Albertini A, Sugherini L, and Pompella A et al. Plasma total antioxidant capacity in hemodiayzed patients and its relationship to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med. 2002;40(2):104-10.